Sangamo Therapeutics, Inc.;Board of Regents, The University of Texas System
发明人:
Philip D. Gregory,Laurence J.N. Cooper,Hiroki Torikai
申请号：
US15490601
公开号：
US20170216358A1
申请日:
2017.04.18
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Disclosed herein are methods and compositions for modulating the expression of a HLA locus, including cells that lack expression of one or more classic HLA genes but are not targeted by Natural Killer (NK) cells for lysis.
